Page last updated: 2024-12-07

nsc 153174

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

NSC 153174: RN given refers to (cis)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID93238
CHEMBL ID12920
CHEMBL ID1990387
CHEMBL ID1964420
MeSH IDM0061858

Synonyms (27)

Synonym
urea, 3-(4-carboxycyclohexyl)-1-(2-chloroethyl)-1-nitroso-, (e)-
trans-4-(3-(2-chloroethyl)-3-nitrosoureido)cyclohexanecarboxylic acid
cyclohexanecarboxylic acid, 4-(3-(2-chloroethyl)-3-nitrosoureido)-, (e)-
nsc 153175
cyclohexanecarboxylic acid, 4-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-, trans-
cis-4-((((2-chloroethyl)nitrosamino)carbonyl)amino)-cyclohexanecarboxylic acid
cyclohexanecarboxylic acid, 4-(3-(2-chloroethyl)-3-nitrosoureido)-, (z)-
cyclohexanecarboxylic acid, 4-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-, cis-
cis-4-(3-(2-chloroethyl)-3-nitrosoureido)cyclohexanecarboxylic acid
cis-acid
nsc153174
42558-94-1
nsc 153174
42558-93-0
cis-cccnu
nsc153175
nsc-153174
nsc-153175
NCI60_001080
NCI60_001079
CHEMBL12920
CHEMBL1990387
4-({[(2-chloroethyl)(nitroso)amino]carbonyl}amino)cyclohexanecarboxylic acid
CHEMBL1964420
DTXSID40195343
cyclohexanecarboxylic acid, 4-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-, trans- (9ci)
4-(3-(2-chloroethyl)-3-nitrosoureido)-cis-cyclohexane-carboxylic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (22)

Assay IDTitleYearJournalArticle
AID1149521Antitumor activity against mouse early Lewis lung carcinoma allografted in ip dosed BDF1 mouse assessed as disease cure administered as single dose on 1 or 2 days post-tumor implantation measured for 80 days post-drug treatment1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
AID1149482Antitumor activity against mouse early Lewis lung carcinoma allografted in BDF1 mouse assessed as increase in host life span at 13 mg/kg, ip administered as single dose on 1 or 2 days post-tumor implantation1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
AID1133741Octanol-water partition coefficient, log P of the compound at pH 7.41977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Synthesis of analogues of N-(2-chloroethyl)-N'-(trans-4-methylcyclohexyl)-N-nitrosourea for evaluation as anticancer agents.
AID1133738Antitumor activity against mouse L1210 cells allografted in ip dosed BDF1 mouse assessed as increase of life span of host measured up to 45 days1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Synthesis of analogues of N-(2-chloroethyl)-N'-(trans-4-methylcyclohexyl)-N-nitrosourea for evaluation as anticancer agents.
AID1149401Antitumor activity against mouse advanced Lewis lung carcinoma allografted in BDF1 mouse assessed as increase in host life span at 20 mg/kg, ip administered as single dose on 7th day post-tumor implantation1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
AID125581Tested for 3 log kill of leukemia cells1980Journal of medicinal chemistry, Oct, Volume: 23, Issue:10
Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia.
AID23276Partition coefficient (logP)1980Journal of medicinal chemistry, Oct, Volume: 23, Issue:10
Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia.
AID134226Toxicity against L-1210 leukemia cells in mice after intraperitoneal administration, activity is expressed as LD101980Journal of medicinal chemistry, Oct, Volume: 23, Issue:10
Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia.
AID1149441Antitumor activity against mouse advanced Lewis lung carcinoma allografted in BDF1 mouse assessed as disease cure at 30 mg/kg, ip administered as single dose on 7th day post-tumor implantation measured for 80 days post-drug treatment1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
AID1149525Antitumor activity against mouse advanced Lewis lung carcinoma allografted in ip dosed BDF1 mouse assessed as complete regression of established tumor administered as single dose on day 6 or 7 post-tumor implantation1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
AID1149454Antitumor activity against mouse advanced Lewis lung carcinoma allografted in BDF1 mouse assessed as disease cure at 20 mg/kg, ip administered as single dose on 7th day post-tumor implantation measured for 80 days post-drug treatment1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
AID1149526Antitumor activity against mouse advanced Lewis lung carcinoma allografted in ip dosed BDF1 mouse assessed as disease cure administered as single dose on day 6 or 7 post-tumor implantation1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
AID1149388Antitumor activity against mouse advanced Lewis lung carcinoma allografted in BDF1 mouse assessed as increase in host life span at 30 mg/kg, ip administered as single dose on 7th day post-tumor implantation1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
AID1133739Therapeutic index, ratio of LD10 for BDF1 mouse to ED50 for mouse L1210 cells allografted in ip dosed BDF1 mouse1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Synthesis of analogues of N-(2-chloroethyl)-N'-(trans-4-methylcyclohexyl)-N-nitrosourea for evaluation as anticancer agents.
AID1149510Antitumor activity against mouse early Lewis lung carcinoma allografted in BDF1 mouse assessed as time delay in tumor growth at 13 mg/kg, ip administered as single dose on 1 or 2 days post-tumor implantation1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
AID1149523Ratio of ED50 for antitumor activity against mouse L1210 cells allografted in ip dosed mouse to LD10 for mouse1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
AID1149481Antitumor activity against mouse early Lewis lung carcinoma allografted in BDF1 mouse assessed as increase in host life span at 20 mg/kg, ip administered as single dose on 1 or 2 days post-tumor implantation1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
AID1133737Toxicity in ip dosed BDF1 mouse1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Synthesis of analogues of N-(2-chloroethyl)-N'-(trans-4-methylcyclohexyl)-N-nitrosourea for evaluation as anticancer agents.
AID1149511Antitumor activity against mouse early Lewis lung carcinoma allografted in BDF1 mouse assessed as time delay in tumor growth at 30 mg/kg, ip administered as single dose on 1 or 2 days post-tumor implantation1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
AID1149483Antitumor activity against mouse early Lewis lung carcinoma allografted in BDF1 mouse assessed as increase in host life span at 30 mg/kg, ip administered as single dose on 1 or 2 days post-tumor implantation1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
AID221726Dose showing lethal effects on 10% of the mice bearing lewis lung tumors.1984Journal of medicinal chemistry, Jan, Volume: 27, Issue:1
cis-4-[[[(2-Chloroethyl)nitrosoamino]carbonyl]methylamino] cyclohexanecarboxylic acid, a nitrosourea with latent activity against an experimental solid tumor.
AID23780Half life period in phosphate buffer (pH 7.4)1984Journal of medicinal chemistry, Jan, Volume: 27, Issue:1
cis-4-[[[(2-Chloroethyl)nitrosoamino]carbonyl]methylamino] cyclohexanecarboxylic acid, a nitrosourea with latent activity against an experimental solid tumor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]